COMPOUND OYSTER PEPTIDE

FDA Drug Profile — COMPOUND OYSTER PEPTIDE

COMPOUND OYSTER PEPTIDE is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including COMPOUND OYSTER PEPTIDE. Available dosage form: capsule.

Drug Details

Generic Name
COMPOUND OYSTER PEPTIDE
Brand Names
COMPOUND OYSTER PEPTIDE
Application Number
Sponsor
Bispit Canada Ltd.
NDC Codes
1
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
LYCIUM CHINENSE FRUIT, ASIAN GINSENG, LICORICE, POLYGONATUM SIBIRICUM WHOLE, PHYLLOLOBIUM CHINENSE SEED, RIBOFLAVIN, ZINC LACTATE, TAURINE, THIAMINE, CORNUS OFFICINALIS WHOLE, SEA CUCUMBER, UNSPECIFIED, DIOSCOREA CAYENENSIS TUBER, WHITE MULBERRY, OYSTER, UNSPECIFIED

Indications and Usage

Thisproductisuable for men.Long em use helpsnouish the kidneys antvila energyenhancephyskcal igoimprowve thequalty of sexual le,imprvemornimg erecions and hardnes,andeeve postcoita fatigue. This product ispurely derived from botanical extracls, making it suitable for long-term use withno reported adverse side effects

Warnings

Not suitable for individuals under 18years of age Do not use if you have a seafood allergy.